UPC Clarifies PI Costs Breakdown In mRNA Fight

By Alex Baldwin ( February 2, 2026, 6:51 PM GMT) -- The Unified Patent Court has held that costs incurred in preliminary injunction actions can not be considered "other expenses" in main proceedings, marking the latest in an ongoing fight over mRNA technology between 10x Genomics and Curio Bioscience....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies